Lifecore Biomedical Inc. (NASDAQ: LFCR) will be added to the Nasdaq Biotech Index (NASDAQ: NBI) effective December 22, 2025, as part of the index's annual reconstitution. The addition follows Lifecore meeting eligibility requirements such as minimum market capitalization, trading volume, and public company seasoning.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lifecore Biomedical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 9604229) on December 18, 2025, and is solely responsible for the information contained therein.

